Medicamen Biotech Limited Cash Flow-to-Debt Ratio
Medicamen Biotech Limited cash flow-to-debt ratio. Medicamen Biotech Limited (MEDICAMEQ) has a Cash Flow-to-Debt Ratio of -0.14x as of September 2025, meaning its operating cash flow of Rs-124.06 Million could theoretically repay 0% of its total liabilities (Rs916.99 Million) in one year. Check MEDICAMEQ operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Medicamen Biotech Limited (2006–2026)
Cash flow-to-debt ratio of Medicamen Biotech Limited from 2006 to 2026. Historical debt coverage capacity for Medicamen Biotech Limited across 21 annual periods. Check MEDICAMEQ cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Medicamen Biotech Limited Cash Flow-to-Debt Ratio by Year (2006–2026)
Medicamen Biotech Limited cash flow-to-debt ratio by year from 2006 to 2026. Year-by-year debt coverage analysis for Medicamen Biotech Limited. For the full cash flow conversion analysis, see MEDICAMEQ cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.36x | Rs-349.31 Million | Rs964.38 Million | ▼ -209.0% |
| 2025 | -0.12x | Rs-98.59 Million | Rs841.04 Million | ▼ -52.2% |
| 2024 | -0.08x | Rs-67.44 Million | Rs875.67 Million | ▼ -4.2% |
| 2023 | -0.07x | Rs-62.93 Million | Rs851.03 Million | ▼ -242.6% |
| 2022 | 0.05x | Rs41.09 Million | Rs792.24 Million | ▼ -75.2% |
| 2021 | 0.21x | Rs127.72 Million | Rs611.18 Million | ▼ -2.0% |
| 2020 | 0.21x | Rs128.02 Million | Rs600.66 Million | ▲ +147.6% |
| 2019 | 0.09x | Rs43.01 Million | Rs499.59 Million | ▲ +167.8% |
| 2018 | -0.13x | Rs-54.54 Million | Rs429.43 Million | ▼ -264.8% |
| 2017 | 0.08x | Rs35.92 Million | Rs466.20 Million | ▼ -47.7% |
| 2016 | 0.15x | Rs62.06 Million | Rs421.09 Million | ▲ +331.7% |
| 2015 | -0.06x | Rs-32.74 Million | Rs514.78 Million | ▼ -159.5% |
| 2014 | 0.11x | Rs51.39 Million | Rs480.41 Million | ▲ +436.7% |
| 2013 | -0.03x | Rs-15.73 Million | Rs495.17 Million | ▲ +55.6% |
| 2012 | -0.07x | Rs-34.90 Million | Rs488.06 Million | ▼ -131.2% |
| 2011 | 0.23x | Rs113.52 Million | Rs496.06 Million | ▲ +762.1% |
| 2010 | 0.03x | Rs11.00 Million | Rs414.22 Million | ▼ -89.5% |
| 2009 | 0.25x | Rs83.07 Million | Rs328.50 Million | ▲ +347.7% |
| 2008 | 0.06x | Rs22.70 Million | Rs401.88 Million | ▲ +693.1% |
| 2007 | 0.01x | Rs2.59 Million | Rs363.44 Million | ▼ -93.1% |
| 2006 | 0.10x | Rs26.02 Million | Rs252.51 Million | — |